Genome mining for the discovery of peptide halogenases and their biochemical characterization.

Methods Enzymol

School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, GA, United States; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, United States. Electronic address:

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

While halogenation is one of the most versatile C-H functionalization strategy, regiospecific halogenation of peptides and proteins is outside the purview of traditional chemical catalysis. Enzymes that participate in the biosynthesis of ribosomally synthesized and post-translationally modified peptides and proteins can bridge this gap and offer a biocatalytic route for residue-specific incorporation of halogen handles onto amino acid side chains. Protocols described herein provide a guided approach for the discovery of peptide halogenases in the context of natural product biosynthetic gene clusters, and the preliminary reconstitution of their activity using a bacterial heterologous host. Also described are mass spectrometry-based analytical procedures and data analysis workflows that allow for deconvolution of halide specificity and preliminary insights into peptidic natural product biosynthetic schemes. As the available genomic data expands at a rapid rate, the methodology described here will enable the discovery and characterization of new halogenases that can be valuable partners in chemoenzymatic diversification of peptides and proteins.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12255868PMC
http://dx.doi.org/10.1016/bs.mie.2025.02.006DOI Listing

Publication Analysis

Top Keywords

peptides proteins
12
discovery peptide
8
peptide halogenases
8
natural product
8
product biosynthetic
8
genome mining
4
mining discovery
4
halogenases biochemical
4
biochemical characterization
4
characterization halogenation
4

Similar Publications

Unlabelled: Despite stimulating glucagon secretion, the mechanisms by which protein ingestion lowers glucose excursions remain unclear. We investigated this using the triple stable isotope glucose tracer technique to measure postprandial glucose fluxes. Eleven healthy adults completed three trials, ingesting 25 g glucose (25G; 100 kcal), 50 g glucose (50G; 200 kcal), or 25 g glucose plus 25 g whey protein (25WG; 200 kcal).

View Article and Find Full Text PDF

Retinol binding protein 4 (RBP4), the circulating carrier of retinol, complexes with transthyretin (TTR) and is a potential biomarker of cardiometabolic disease. However, RBP4 quantitation relies on immunoassays and Western blots without retinol and TTR measurement. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous absolute quantitation of circulating RBP4 and TTR is critical to establishing their biomarker potential.

View Article and Find Full Text PDF

Background: A secondary Pasteurella multocida (Pm) infection following Mycoplasma ovipneumoniae (Mo) challenge in sheep results in severe respiratory disease. Scavenger receptor A (SRA) is a key phagocytic receptor on macrophages, which facilitates microbial clearance. However, the role of sheep SRA in Mo-associated secondary Pm infection is less understood.

View Article and Find Full Text PDF

Proteomic characterization and lethality of the venom of the Black Judean scorpion, Hottentotta judaicus (Buthidae): expanded toxin diversity and revisited toxicological significance.

Arch Toxicol

September 2025

Laboratorio de Proteómica, Facultad de Microbiología, Instituto Clodomiro Picado, Universidad de Costa Rica, San José, 11501, Costa Rica.

The scorpion Hottentotta judaicus inhabits the Levant region of the Middle East, including Lebanon, Jordan, Palestine, and Israel. While previous research focused on its insecticidal properties and sodium-channel-targeting toxins, its venom remains largely unexplored using modern proteomic approaches. We analyzed the venom composition of H.

View Article and Find Full Text PDF

Immunogenic cell death (ICD) is a type of cell death sparking adaptive immune responses that can reshape the tumor microenvironment. Exploring key ICD-related genes in bladder cancer (BLCA) could enhance personalized treatment. The Cancer Genome Atlas (TCGA) BLCA patients were divided into two ICD subtypes: ICD-high and ICD-low.

View Article and Find Full Text PDF